marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Petros Pharmaceuticals Financial Statements 2011-2024 | PTPI
Annual Financial Statements Petros Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.05 M | 3.11 M | 1.5 M | 32.6 M | - | - | - | - | - | - | - | - | - |
Shares |
2.18 M | 2.07 M | 1.09 M | 9.71 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
1.4 | 1.5 | 1.38 | 3.33 | - | - | - | - | - | - | - | - | - |
Net Income |
-8.16 M | -20 M | -8.99 M | -20.6 M | -32.5 M | - | - | - | - | - | - | - | - |
Revenue |
5.82 M | 5.99 M | 7.81 M | 9.56 M | 15.6 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.63 M | 2.29 M | 1.6 M | 4.05 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
4.19 M | 3.7 M | 6.21 M | 5.51 M | 8.15 M | - | - | - | - | - | - | - | - |
Operating Income |
-13.6 M | -19.9 M | -18 M | -17.3 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
5.45 M | -122 K | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-10.3 M | -14.3 M | -11.2 M | -10.6 M | -11.6 M | - | - | - | - | - | - | - | - |
Operating Expenses |
17.8 M | 23.6 M | 24.3 M | 22.8 M | 25 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
9.26 M | 12.2 M | 15.6 M | 15.7 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Petros Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
9.83 M | 7.39 M | 4.76 M | 2.99 M | 2.12 M | 2.12 M | 2.09 M | 2.08 M | 2.07 M | 2.07 M | 2.07 M | 20.7 M | 9.83 M | 9.8 M | 9.75 M | 9.71 M | 3.43 M | 3.43 M | 3.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-2.22 M | -662 K | -2.16 M | - | -4.55 M | -2.55 M | -1.39 M | - | -13.8 M | -1.81 M | -174 K | - | -1.7 M | -2.11 M | 3.01 M | - | -3.3 M | -5.76 M | -11.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
1.58 M | 1.42 M | 1.39 M | - | 1.67 M | 1.99 M | 2.52 M | - | 5.19 M | 4.19 M | 2.47 M | - | 2.15 M | 2.46 M | 4.08 M | - | 3.46 M | 1.37 M | 3.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
287 K | 329 K | 332 K | - | 408 K | 514 K | 551 K | - | 287 K | 649 K | 472 K | - | 319 K | 393 K | 643 K | - | 982 K | 539 K | 1.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
1.29 M | 1.09 M | 1.06 M | - | 1.27 M | 1.48 M | 1.97 M | - | -1.74 M | 3.54 M | 1.99 M | - | 1.83 M | 2.06 M | 3.43 M | - | 2.48 M | 834 K | 1.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.34 M | -2.28 M | -3.93 M | - | -4.81 M | -2.46 M | -1.31 M | - | -13.7 M | -1.66 M | -481 K | - | -3.6 M | -4.28 M | -2.2 M | - | -2.34 M | -5.02 M | -10.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
119 K | 1.62 M | 1.77 M | - | 257 K | -83.9 K | -75.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-1.6 M | -1.56 M | -3.21 M | - | -3.98 M | -1.64 M | -483 K | - | -12.1 M | -101 K | 1.08 M | - | -1.87 M | -2.55 M | -469 K | - | -675 K | -3.36 M | -7.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
3.63 M | 3.37 M | 4.99 M | - | 6.07 M | 3.94 M | 3.28 M | - | 11.9 M | 5.2 M | 2.47 M | - | 5.42 M | 6.35 M | 5.63 M | - | 4.82 M | 5.85 M | 12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.3 M | 2.29 M | 2.71 M | - | 2 M | 2.25 M | 2.13 M | - | 2.17 M | 3.22 M | 3.9 M | - | 3.41 M | 4.12 M | 3.88 M | - | 3.12 M | 4.06 M | 8.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency